Breadcrumb

profile photo

Hyunmi Halas, Ph.D.

  • Center for Cancer Research
  • National Cancer Institute
Surgery Branch

RESEARCH SUMMARY

Dr. Halas is the head of the Surgery Branch T30 Cell Production Facility, a state-of-the-art cGMP facility dedicated to cellular therapy manufacturing and tumor processing for the Surgery Branch. She oversees a team of senior scientists and highly experienced technicians who assist in the development of all manufacturing processes.  Her team manufactures the final experimental cellular product including Tumor Infiltrating Lymphocytes (TIL), CAR-T cells, and genetically-modified lymphocytes (TCRs) administered to patients enrolled on Surgery Branch clinical trials.  In addition, she assists in the development of shared systems and process improvements for NCI SB manufacturing facilities with the aide of the manufacturing team, clinical team, regulatory and Quality Assurance groups to ensure the processes implemented to manufacture patient therapies are compliant with current standards and regulations.

Areas of Expertise

Cell Manufacturing

Team

Head of Process Development
Frank Lowery, Ph.D.
n
Research Fellow
Nivedita (Nivi) Ratnam, Ph.D.
Biologist/Researcher
Zhili Zheng, M.S.
Staff Scientist/Facility Logistics Manager
Xu Zhao, M.D., Ph.D.
Biologist/Cell Production Coordinator
Michelle Langhan, MPH
Management Analyst
Carol Bryant, B.S.
Biologist/Researcher
Hui Xu
Manufacturing Technician - Gene Therapy Group
Nadia Ruiz Torres, Ph.D.
Manufacturing Technician - Gene & TIL Therapy Groups
Francis Cobarde, B.S.
Tech Lab Manager/Sr. Manufacturing Technician - TIL Therapy Group
Thomas (Tom) Shelton, M.S.
d
Post-Baccalaureate
David Komjathy, B.S.
K
Post-Baccalaureate
Kevin Ezhakunnel, B.S.
Manufacturing Associate
Joel Landman, B.S.
Manufacturing Associate
Ayoub Tazi, B.S.
Elie
post-baccalaureate
Elie Abecassis